AU2006330769A1 - Antimicrobial cathelicidin peptides - Google Patents

Antimicrobial cathelicidin peptides Download PDF

Info

Publication number
AU2006330769A1
AU2006330769A1 AU2006330769A AU2006330769A AU2006330769A1 AU 2006330769 A1 AU2006330769 A1 AU 2006330769A1 AU 2006330769 A AU2006330769 A AU 2006330769A AU 2006330769 A AU2006330769 A AU 2006330769A AU 2006330769 A1 AU2006330769 A1 AU 2006330769A1
Authority
AU
Australia
Prior art keywords
polypeptide
variant
fragment
nucleic acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006330769A
Other languages
English (en)
Inventor
Frank Blecha
Tonatiuh Melgarejo
Maria Teresa Ortega
Yongming Sang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kansas State University
Original Assignee
Kansas State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansas State University filed Critical Kansas State University
Publication of AU2006330769A1 publication Critical patent/AU2006330769A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2006330769A 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides Abandoned AU2006330769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75487805P 2005-12-29 2005-12-29
US60/754,878 2005-12-29
PCT/US2006/049637 WO2007076162A2 (en) 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides

Publications (1)

Publication Number Publication Date
AU2006330769A1 true AU2006330769A1 (en) 2007-07-05

Family

ID=38218737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006330769A Abandoned AU2006330769A1 (en) 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides

Country Status (8)

Country Link
US (1) US7985832B2 (cg-RX-API-DMAC7.html)
EP (1) EP1966235A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009521932A (cg-RX-API-DMAC7.html)
CN (1) CN101351474A (cg-RX-API-DMAC7.html)
AU (1) AU2006330769A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0621148A2 (cg-RX-API-DMAC7.html)
CA (1) CA2632782A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007076162A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US8710272B2 (en) 2007-01-08 2014-04-29 Androscience Corporation Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
US9000222B2 (en) 2007-01-08 2015-04-07 Androscience Corporation Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
AU2008205312B2 (en) 2007-01-08 2013-11-21 Annji Pharmaceutical Co., Ltd. Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
MX2010001125A (es) 2007-07-31 2010-09-30 Androscience Corp Composiciones incluyendo receptor androgeno de degradacion (ard) ponteciadores y metodos de tratamiento profilactico o terapeutico de trastornos de la piel y la caida de cabello.
AU2008310076A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag CGRP as a therapeutic agent
KR20100061481A (ko) * 2007-09-11 2010-06-07 몬도바이오테크 래보래토리즈 아게 치료제로서의 미니가스트린
CA2776883A1 (en) * 2009-06-16 2010-12-23 George Mason Intellectual Properties, Inc. Antimicrobial and antibiofilm activity of cathelicidins
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore
CN104010653B (zh) 2011-10-31 2019-01-01 凯恩生物科技有限公司 用于预防并治疗口腔疾病的组合物和方法
WO2015196299A1 (en) * 2014-06-27 2015-12-30 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US10357470B2 (en) 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
US10046137B2 (en) 2014-02-21 2018-08-14 Avadim Technologies, Inc. Method for maintenance of urethral catheters
ES2789351T3 (es) 2015-01-13 2020-10-26 Hope City Máscaras de enlace peptídico de proteínas de unión a CTLA4
CN104830891B (zh) * 2015-03-23 2017-10-31 广东药科大学 一种金环蛇抗菌肽Cath‑BF30的高效制备方法
US20190352377A1 (en) * 2016-11-15 2019-11-21 The Rockefeller University Chimeric antibodies comprising binding domains of phage lysins, bacterial autolysins, bacteriocins, and phage tail or tail fibers
CN109996554B (zh) * 2016-11-21 2024-03-29 匹兹堡大学联邦高等教育系统 新型抗微生物和抗癌疗法
CN109266655B (zh) * 2018-09-06 2021-11-09 浙江大学 一种抗菌肽及其原核表达方法和应用
CA3143518A1 (en) * 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
CN110590927B (zh) * 2019-09-17 2022-06-14 济宁医学院 多疣壁虎抗氧化肽及其应用
CN111374317B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374169B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
CN1878789A (zh) 2003-10-21 2006-12-13 加利福尼亚大学董事会 人凯萨林菌素抗微生物肽
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
KR101326133B1 (ko) 2005-03-10 2013-11-06 삼성디스플레이 주식회사 평판 표시 장치 제조 시스템
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
EP2200628A2 (en) * 2007-07-15 2010-06-30 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors

Also Published As

Publication number Publication date
US7985832B2 (en) 2011-07-26
EP1966235A4 (en) 2010-01-06
WO2007076162A3 (en) 2008-09-12
EP1966235A2 (en) 2008-09-10
US20090221483A1 (en) 2009-09-03
CA2632782A1 (en) 2007-07-05
WO2007076162A2 (en) 2007-07-05
JP2009521932A (ja) 2009-06-11
BRPI0621148A2 (pt) 2011-11-29
CN101351474A (zh) 2009-01-21

Similar Documents

Publication Publication Date Title
US7985832B2 (en) Antimicrobial cathelicidin peptides
US5948408A (en) DNA encoding bactericidal/permeability-increasing proteins
EP0652230B1 (en) Biologically active bactericidal/permeability-increasing protein fragments
Sang et al. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide
KR101949210B1 (ko) 항염증 활성을 가진 인간 락토페린계 펩타이드
AU2012210565A1 (en) Human lactoferrin derived peptides and there use
AU2012210564A1 (en) Human lactoferrin based peptides having antiinflammatory activity
JP2011503137A (ja) 新規のアルギニン置換ペプチド及びその使用
EP2349317A2 (en) Treatment of intracellular bacterial infections
WO2007064903A1 (en) Fowlicidins and methods of their use
WO2009121828A1 (en) Use of defensins against meningitis
WO2003087143A2 (en) Human polypeptides having antibacterial activity
Mookherjee et al. Cathelicidins: cationic host defense and antimicrobial peptides
Cao et al. In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period